TOCQUEVILLE ASSET MANAGEMENT L.P. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$238,000
-45.8%
3,500
-74.5%
0.01%
-37.5%
Q2 2022$439,000
-7.8%
13,7500.0%0.01%
+14.3%
Q1 2022$476,000
+51.1%
13,750
+27.9%
0.01%
+75.0%
Q4 2021$315,000
-13.2%
10,750
+21.5%
0.00%
-20.0%
Q4 2018$363,000
-8.1%
8,850
-14.9%
0.01%0.0%
Q3 2018$395,000
-2.5%
10,400
+16.2%
0.01%0.0%
Q2 2018$405,000
+0.5%
8,950
+7.2%
0.01%0.0%
Q1 2018$403,0008,3500.01%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2018
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders